A detailed history of Kornitzer Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 129,940 shares of LLY stock, worth $97.2 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares
129,940
Previous 132,200 1.71%
Holding current value
$97.2 Million
Previous $120 Million 3.82%
% of portfolio
2.21%
Previous 2.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$772.14 - $960.02 $1.75 Million - $2.17 Million
-2,260 Reduced 1.71%
129,940 $115 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $3.77 Million - $4.72 Million
-5,197 Reduced 3.78%
132,200 $120 Million
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $6.26 Million - $8.37 Million
-10,570 Reduced 7.14%
137,397 $107 Million
Q4 2023

Jan 31, 2024

SELL
$525.19 - $619.13 $2.72 Million - $3.21 Million
-5,187 Reduced 3.39%
147,967 $86.3 Million
Q3 2023

Oct 31, 2023

SELL
$434.7 - $599.3 $601,624 - $829,431
-1,384 Reduced 0.9%
153,154 $82.3 Million
Q2 2023

Aug 01, 2023

SELL
$350.74 - $468.98 $2.33 Million - $3.11 Million
-6,629 Reduced 4.11%
154,538 $72.5 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $956,740 - $1.12 Million
-3,080 Reduced 1.88%
161,167 $55.3 Million
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $495,187 - $576,991
-1,540 Reduced 0.93%
164,247 $60.1 Million
Q3 2022

Nov 03, 2022

SELL
$296.48 - $337.87 $898,334 - $1.02 Million
-3,030 Reduced 1.79%
165,787 $53.6 Million
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $3.33 Million - $3.91 Million
-11,960 Reduced 6.62%
168,817 $54.7 Million
Q1 2022

Apr 27, 2022

SELL
$234.69 - $291.66 $614,653 - $763,857
-2,619 Reduced 1.43%
180,777 $51.8 Million
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $1.14 Million - $1.41 Million
-5,057 Reduced 2.68%
183,396 $50.7 Million
Q3 2021

Nov 03, 2021

SELL
$221.6 - $272.71 $340,156 - $418,609
-1,535 Reduced 0.81%
188,453 $43.5 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $1.99 Million - $2.57 Million
-11,005 Reduced 5.48%
189,988 $43.6 Million
Q1 2021

Apr 30, 2021

SELL
$164.32 - $212.72 $959,957 - $1.24 Million
-5,842 Reduced 2.82%
200,993 $37.6 Million
Q4 2020

Jan 29, 2021

SELL
$130.46 - $172.63 $156,160 - $206,638
-1,197 Reduced 0.58%
206,835 $34.9 Million
Q3 2020

Oct 30, 2020

SELL
$146.22 - $169.13 $1.29 Million - $1.49 Million
-8,835 Reduced 4.07%
208,032 $30.8 Million
Q2 2020

Aug 03, 2020

SELL
$136.42 - $164.18 $3.92 Million - $4.71 Million
-28,718 Reduced 11.69%
216,867 $35.6 Million
Q1 2020

Apr 30, 2020

SELL
$119.05 - $147.35 $1.74 Million - $2.15 Million
-14,615 Reduced 5.62%
245,585 $34.1 Million
Q4 2019

Jan 31, 2020

SELL
$106.92 - $132.43 $995,425 - $1.23 Million
-9,310 Reduced 3.45%
260,200 $34.2 Million
Q3 2019

Nov 04, 2019

SELL
$106.79 - $116.16 $558,511 - $607,516
-5,230 Reduced 1.9%
269,510 $30.1 Million
Q2 2019

Jul 31, 2019

SELL
$110.79 - $129.32 $251,493 - $293,556
-2,270 Reduced 0.82%
274,740 $30.4 Million
Q1 2019

May 01, 2019

SELL
$111.31 - $131.02 $271,039 - $319,033
-2,435 Reduced 0.87%
277,010 $35.9 Million
Q4 2018

Jan 31, 2019

SELL
$105.9 - $118.64 $337,821 - $378,461
-3,190 Reduced 1.13%
279,445 $32.3 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $218,084 - $272,567
-2,540 Reduced 0.89%
282,635 $30.3 Million
Q2 2018

Aug 02, 2018

SELL
$75.7 - $86.88 $134,140 - $153,951
-1,772 Reduced 0.62%
285,175 $24.3 Million
Q1 2018

Apr 30, 2018

SELL
$74.21 - $87.6 $32,281 - $38,106
-435 Reduced 0.15%
286,947 $22.2 Million
Q4 2017

Jan 31, 2018

SELL
$81.94 - $87.89 $713,287 - $765,082
-8,705 Reduced 2.94%
287,382 $24.3 Million
Q3 2017

Oct 31, 2017

BUY
$77.07 - $85.54 $22.8 Million - $25.3 Million
296,087
296,087 $25.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.